DUCHENE TODD M 4

What Happened
Todd M. Duchene, Core Scientific's Chief Legal and Administrative Officer, sold a total of 10,000 shares in open-market transactions on June 1, 2026, disposing of: 1,300 shares at a weighted avg price of $26.93 ($35,007); 3,200 shares at $28.27 ($90,453); and 5,500 shares at $28.76 ($158,159). Total proceeds were approximately $283,619. These were sales (not purchases), which are often routine rather than a bullish signal.

Key Details

• Transaction date: 2026-06-01; Form 4 filed: 2026-06-03 (timely filing).
• Share breakdown and reported prices:
  • 1,300 shares — $26.93 weighted average (sales ranged $26.54–$27.52) [Footnote F2]
  • 3,200 shares — $28.27 weighted average (sales ranged $27.57–$28.56) [Footnote F3]
  • 5,500 shares — $28.76 weighted average (sales ranged $28.58–$28.97) [Footnote F4]
• Total shares sold: 10,000; total proceeds ≈ $283,619.
• Shares owned after the transactions: not disclosed in the provided excerpt of the filing.
• Notable: Transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted Dec 5, 2025 (Footnote F1). The weighted-average prices reflect multiple trades; the filer offers to provide per-trade price details on request.

Context

• A 10b5-1 plan typically means trades were pre-scheduled and may be routine, reducing the implication that sales reflect immediate insider views on the company.
• Sales (code "S") are less informative than purchases for signaling insider confidence; treat as factual disclosure rather than a recommendation.